Skip to main content
. 2017 May 19;8(31):51416–51428. doi: 10.18632/oncotarget.18006

Figure 1. mRNA assessment of tumor biomarkers in metastatic tumor (MT) vs. primary (PT) tumor samples, by biopsy site.

Figure 1